4.5 Article

Programmed necrosis in heart disease: Molecular mechanisms and clinical implications

期刊

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
卷 116, 期 -, 页码 125-134

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.yjmcc.2018.01.018

关键词

Programmed necrosis; Apoptosis; Necroptosis; MPT-dependent necrosis; Heart disease; Clinical implications

资金

  1. National Natural Science Foundation of China [81570224]
  2. Innovative Research Groups of the National Natural Science Foundation of China [81521001]
  3. National Science Fund for Distinguished Young Scholars [81725002]
  4. Major Research Plan of the National Natural Science Foundation of China [91639104]

向作者/读者索取更多资源

Programmed cell death plays an essential role in myocardial homeostasis and pathology. Three distinct forms of programmed cell death have been identified, namely apoptosis, necrosis, and autophagic cell death. Necrosis, previously known as an unregulated form of cell death, has been recognized as a highly regulated process now and attracted great attention over the past decade. Programmed necrosis mainly refers to necroptosis, pyroptosis, ferroptosis, and mitochondria! permeability transition (MPT)-dependent necrosis. Among them, role of necroptosis and MPT-dependent necrosis in the pathogenesis of heart disease, mainly including myocardial infarction (MI), ischemia/reperfusion (I/R), and heart failure is well defined now. Necroptosis is orchestrated by a complex of proteins involving receptor-interacting protein kinase 1 (RIPK1), RIPK3 and mixed lineage kinase domain-like protein (MLKL). While MPT-dependent necrosis is another modality of necrosis characterized by MPT pore opening and cyclophilin-D (CypD)-dependent death signaling. Of note, the observed effects of necrostatin-1 (Nec-1, inhibitor of RIPK1) and cyclosporine A (CsA, inhibitor of CypD) on attenuating programmed necrosis and related cardiac injury further demonstrated the significant role of programmed necrosis in dictating cell demise and shed light on their further clinical application, along with other types of inhibitors targeting programmed necrosis. In this review, we summarized the recent progress on programmed necrosis in heart disease from molecular mechanisms to therapeutic strategies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据